Empower Clinics Inc. – OTC:EPWCF

Add to watchlist

$0.018

+0.01

+1799900%

Market closed

Open in 2 days

-100.00%

month

-100.00%

quarter

-100.00%

year

Market Cap	6.79M
Enterprise value	6.48M

P/E	-0.3
EV/Sales	1.20
EV/EBITDA	-0.79
Price/Sales	0.38
Price/Book	-0.39
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	-100%
Revenue Y/Y	-92.05%

Profit margin	-170.89%
Oper. margin	-108.22%
Gross margin	30.04%
EBIT margin	-108.22%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Empower Clinics Inc. (OTC:EPWCF): Profit margin
Dec 2022	427.43K	-2.37M	-555.47%
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

Empower Clinics Inc. (OTC:EPWCF): Debt to assets
Sep 2022	3450154	8.80M	255.13%
Mar 2023	0	0
Jun 2023	0	0
Sep 2023	0	0

Empower Clinics Inc. (OTC:EPWCF): Cash Flow
Dec 2022	-522.38K	1.05K	263.72K
Mar 2023	0	0	0
Jun 2023	0	0	0
Sep 2023	0	0	0

Empower Clinics
Latest News

Friday, 18 August 2023
19:55	Empower Clinics Provides Corporate Update	accesswire.com
Tuesday, 15 August 2023
08:30	Empower Clinics Announces Closing of Second Tranche Private Placement Financing	accesswire.com
Wednesday, 9 August 2023
06:30	Empower Clinics Announces Closing of First Tranche Private Placement Financing	accesswire.com
Tuesday, 1 August 2023
06:30	Empower Clinics Announces Proposal For Division Spin Out	accesswire.com
Monday, 31 July 2023
06:30	Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors	accesswire.com
Tuesday, 6 June 2023
08:18	Empower Clinics signs letter of intent for equity capital facility	Proactive Investors
Tuesday, 9 May 2023
09:19	Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value	Proactive Investors
Wednesday, 3 May 2023
08:17	Empower Clinics signs fourth principal investigator for Dallas site	Proactive Investors
Tuesday, 25 April 2023
08:12	Empower Clinics adds two new researchers to support clinical trials services at its site in Dallas	Proactive Investors
Monday, 17 April 2023
07:47	Empower Clinics signs clinical trials services deal with Texas medical group	Proactive Investors
Tuesday, 21 March 2023
07:44	Empower Clinics commences process to explore and evaluate strategic options	Proactive Investors
Tuesday, 7 March 2023
07:54	Empower Clinics advances partnership to launch US clinical trial management services	Proactive Investors
Wednesday, 1 March 2023
07:03	Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services	Proactive Investors
Tuesday, 7 February 2023
09:54	Empower Clinics partners with nuclear medicine specialist to launch US clinical trial management services	Proactive Investors
Thursday, 2 February 2023
06:44	Empower Clinics announces partnership with Fobi AI unit to elevate investor relations with digital, mobile and personalized engagement	Proactive Investors
Wednesday, 25 January 2023
06:52	Empower Clinics says subsidiary MediSure's diabetes test strips get OK for government programs	Proactive Investors
Tuesday, 24 January 2023
06:44	Empower Clinics announces an offering of units at a price of 3 cents each for aggregate gross proceeds of between $2M and $5M	Proactive Investors
Wednesday, 11 January 2023
06:59	Empower Clinics consolidates three medical clinics to focus on flagship Etobicoke integrated medical clinic	Proactive Investors
Tuesday, 10 January 2023
07:03	Empower Clinics says MediSure Laboratory signs laboratory services agreement with Alp MedTech AG	Proactive Investors
Tuesday, 27 December 2022
09:02	Empower Clinics taps Zeifmans LLP as new auditor as it boosts accounting and financial controls	Proactive Investors
Monday, 19 December 2022
10:54	Empower Clinics inks partnership deal to sell FDA-approved Atlas Medical products in US	Proactive Investors
Wednesday, 14 December 2022
10:16	Empower Clinics announces closing of private placement, resignation of auditor and leadership transition at MediSure Canada	Proactive Investors
Wednesday, 7 December 2022
12:42	Empower Clinics partners up with Specialty Networks of North America to address underserved communities in the US	Proactive Investors
Monday, 28 November 2022
06:46	Empower Clinics sees Q3 revenue nearly triple thanks to COVID-19 testing,higher MediSure sales	Proactive Investors
Thursday, 24 November 2022
06:45	Empower Clinics announces appointment of Eric Christian as new General Manager at Medisure Labs	Proactive Investors
Tuesday, 22 November 2022
06:51	Empower Clinics announces proposed private placement, amendment of warrant terms and debt settlement	Proactive Investors
Thursday, 17 November 2022
10:52	Empower Clinics subsidiary inks MOU with Heart Wellness Cardiac Clinics to provide cardiology services	Proactive Investors
Monday, 14 November 2022
07:41	Empower Clinics appoints US healthcare executive Alexis Wukich to its board	Proactive Investors
Wednesday, 9 November 2022
08:58	Empower Clinics subsidiary MediSure Canada wins three-year contract from Correctional Service of Canada	Proactive Investors
Tuesday, 8 November 2022
08:23	Empower Clinics resumes trading with new Canadian stock symbol	Proactive Investors

Frequently Asked Questions (FAQ)

What's the price of Empower Clinics stock today?

One share of Empower Clinics stock can currently be purchased for approximately $0.02.
When is Empower Clinics's next earnings date?

Unfortunately, Empower Clinics's (EPWCF) next earnings date is currently unknown.
Does Empower Clinics pay dividends?

No, Empower Clinics does not pay dividends.
How much money does Empower Clinics make?

Empower Clinics has a market capitalization of 6.79M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.47% to 4.48M US dollars.
What is Empower Clinics's stock symbol?

Empower Clinics Inc. is traded on the OTC under the ticker symbol "EPWCF".
What is Empower Clinics's primary industry?

Company operates in the Healthcare sector and Medical Care Facilities industry.
How do i buy shares of Empower Clinics?

Shares of Empower Clinics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Empower Clinics went public?

Empower Clinics Inc. is publicly traded company for more then 24 years since IPO on 21 Jun 2001.
What is Empower Clinics's official website?

The official website for Empower Clinics is empowerclinics.com.
Where are Empower Clinics's headquarters?

Empower Clinics is headquartered at 1030 West Georgia Street, Vancouver, BC.
How can i contact Empower Clinics?

Empower Clinics's mailing address is 1030 West Georgia Street, Vancouver, BC.

Empower Clinics Inc.

empowerclinics.com

Exchange:

OTC

Full time employees:

Industry:

Medical Care Facilities

Sector:

Healthcare

Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through medical clinics, digital and telemedicine care, and medical diagnostics laboratories in the United States and Canada. The company also distributes medical devices. Empower Clinics Inc. was incorporated in 1997 and is headquartered in Vancouver, Canada.

1030 West Georgia Street
Vancouver, BC V6G 1C9

CIK: 0001109504
ISIN: CA29246V1040
CUSIP: 29246V104